通过降低miR155水平,L-氨酸减轻了Streptococcus uberis诱导的炎症
Yabing Gao1, Jinye Lu2, Zhenglei Wang1
1MOE Joint International Research Laboratory of Animal Health and Food Safety, Key Laboratory of Animal Physiology & Biochemistry, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.
International immunopharmacology
|February 19, 2024
概括
补充L-氨酸可以降低miR155,减轻由Streptococcus uberis感染引起的炎症和组织损伤. 这项研究揭示了miR1555.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 分子生物学分子生物学
背景情况:
- 对于天生的免疫力来说,L-氨酸至关重要.
- 微RNA 155 (miR155) 调节免疫细胞的稳态.
- 在细菌感染中L-氨酸和miR155之间的相互作用仍然不清楚.
研究的目的:
- 调查miR155在Streptococcus uberis感染期间炎症中的作用.
- 在这种情况下,阐明L-氨酸的分子调节机制.
- 探索细菌性乳腺炎的潜在治疗策略.
主要方法:
- 使用了感染Streptococcus uberis.is的小鼠乳腺炎模型.
- 在感染后测量了miR155表达水平.
- 评估L-氨酸水平和氨基酸代谢.
- 研究了p65信号通路和SOCS6相互作用.
- 评估了补充L-氨酸的效果.
主要成果:
- 杆菌感染导致miR155的增加和L-氨酸的耗尽.
- 上调的miR155通过抑制SOCS6介导的p65降解来促进炎症.
- 补充L-氨酸减少了miR155的表达,并产生抗炎作用.
- 观察到与miR155上调和L-氨酸耗尽相关的严重组织损伤.
结论:
- 在S. uberis感染中,MiR155通过调节p65通路,起到促炎作用.
- 通过抑制miR155的产生,L-氨酸表现出抗炎性质.
- 这项研究为管理细菌性乳腺炎和确保食品安全提供了新的见解.
相关概念视频
Gastritis-II: Pathophysiology
326
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
326
Antimicrobial Proteins
990
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
990
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
429
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
429


